References
- Sorkin N, Varssano D. Corneal collagen crosslinking: a systematic review. Ophthalmologica. 2014;232(1):10–27. doi:10.1159/000357979
- Boyd K. Keratoconus diagnosis and treatment. Am Acad Ophthalmol. 2020. Available from: https://www.aao.org/eye-health/diseases/keratoconus-diagnosis. Accessed January 22, 2021.
- Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135(5):620–627. doi:10.1016/S0002-9394(02)02220-1
- Munir WM. Corneal crosslinking. Am Acad Ophthalmol. 2016. Available from: https://www.aao.org/current-insight/corneal-crosslinking. Accessed January 22, 2021.
- Koller T, Seiler T. [Therapeutic cross-linking of the cornea using riboflavin/UVA]. Klin Monbl Augenheilkd. 2007;224(9):700–706. German. doi:10.1055/s-2007-963492
- Kanellopoulos AJ. Long term results of a prospective randomized bilateral eye comparison trial of higher fluence, shorter duration ultraviolet A radiation, and riboflavin collagen cross-linking for progressive keratoconus. Clin Ophthalmol. 2012;6:97–101. doi:10.2147/OPTH.S27170
- Kanellopoulos AJ, Binder PS. Management of corneal ectasia after LASIK with combined, same-day, topography-guided partial transepithelial PRK and collagen cross-linking: the Athens protocol. J Refract Surg. 2011;27(5):323–331. doi:10.3928/1081597X-20101105-01
- Motwani M, Pei R. The use of WaveLight Contoura to create a uniform cornea: 6-month results with subjective patient surveys. Clin Ophthalmol. 2018;12:1559–1566. doi:10.2147/OPTH.S175661
- Mathew J, Stonecipher K. Wavefront optimized versus topography guided corneal ablations with WaveLight® Platform: a summary of visual outcomes. White paper; 2020. Available from: https://us.alconscience.com/wp-content/uploads/2020/10/Wavefront-Optomized-Versus-Topography-Guided-Corneal-Ablations-With-WaveLight-Platform_A-Summary-Of-Visual-Outcomes-US-ALL-2000003.pdf. Accessed January 22, 2021.
- Vimont C. Corneal collagen cross-linking approved to treat keratoconus in U.S. Am Acad Ophthalmol. 2016. Available from: https://www.aao.org/eye-health/news/cross-linking-approved-keratoconus-united-states. Accessed January 22, 2021.
- Motwani M. A protocol for topographic-guided corneal repair utilizing the US Food and Drug Administration-approved wavelight contoura. Clin Ophthalmol. 2017;11:573–581. doi:10.2147/OPTH.S127855
- Seiler TG, Fischinger I, Senfft T, Schmidinger G, Seiler T. Intrastromal application of riboflavin for corneal crosslinking. Invest Ophthalmol Vis Sci. 2014;55(7):4261–4265. doi:10.1167/iovs.14-14021
- Lin DT, Holland SR, Rocha KM, Krueger RR. Method for optimizing topography-guided ablation of highly aberrated eyes with the ALLEGRETTO WAVE excimer laser. J Refract Surg. 2008;24(4):S439–S445. doi:10.3928/1081597X-20080401-22
- Motwani M. The use of WaveLight((R)) contoura to create a uniform cornea: the LYRA protocol. Part 1: the effect of higher-order corneal aberrations on refractive astigmatism. Clin Ophthalmol. 2017;11:897–905. doi:10.2147/OPTH.S133839
- Awwad ST, Chacra LM, Helwe C, et al. Mitomycin C application after corneal cross-linking for keratoconus increases stromal haze. J Refract Surg. 2021;37(2):83–90. doi:10.3928/1081597X-20201124-01